1,7-dimethylxanthinePapers
Papers about 1,7-dimethylxanthine
- papers
- 105
Newest first
51 to 100 of 105Every paper here, unless its row says otherwiseIndexed under 1,7-dimethylxanthine in PubMed's chemical list
Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
Clinical pharmacology and therapeutics2005PMID 16198659
Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.
European journal of clinical pharmacology2005PMID 16261361
Salivary caffeine metabolic ratio in alcohol-dependent subjects.
European journal of clinical pharmacology2004PMID 15022032
Serum metabolite/caffeine ratios as a test for liver function.
Journal of clinical pharmacology2004PMID 15051740
Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway.
International immunopharmacology2004PMID 15313438
Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine.
Journal of applied physiology (Bethesda, Md.2003PMID 12482764
Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues.
American journal of veterinary research2003PMID 12602592
Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.
Clinical pharmacology and therapeutics2003PMID 12621391
Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.
Journal of the Medical Association of Thailand2003PMID 12930004
CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.
Cancer epidemiology, biomarkers & prevention2002PMID 11927498
Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.
Biochemical pharmacology2002PMID 12110375
Caffeine potentiates the discriminative-stimulus effects of nicotine in rats.
Psychopharmacology2002PMID 12172692
Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.
Biochemical pharmacology2001PMID 11226378
In vivo effect of clarithromycin on multiple cytochrome P450s.
Drug metabolism and disposition: the biological fate of chemicals2001PMID 11408369
Urinary biomarkers for assessing dietary exposure to caffeine.
Food additives and contaminants2001PMID 11761118
Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.
British journal of clinical pharmacology2000PMID 10671909
The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians.
European journal of clinical pharmacology2000PMID 10877011
Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.
Pharmacogenetics1999PMID 10376760
Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.
Biomedical chromatography1999PMID 10416066
Chronic effects of xanthines on levels of central receptors in mice.
Cellular and molecular neurobiology1999PMID 10456233
Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women.
Journal of clinical pharmacology1999PMID 10471985
Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion.
The New England journal of medicine1999PMID 10572151
Omeprazole weakly inhibits CYP1A2 activity in man.
International journal of clinical pharmacology and therapeutics1999PMID 10584979
Serum caffeine and paraxanthine as markers for reported caffeine intake in pregnancy.
Annals of epidemiology1998PMID 9491935
Simple high-performance liquid chromatography method for the simultaneous determination of serum caffeine and paraxanthine following rapid sample preparation.
Journal of chromatography1998PMID 9613939
Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Cancer epidemiology, biomarkers & prevention1996PMID 8877060
Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.
Pharmacogenetics1996PMID 9156694
Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.
Cancer epidemiology, biomarkers & prevention1995PMID 7742721
Sympathomimetic effects of paraxanthine and caffeine in humans.
Clinical pharmacology and therapeutics1995PMID 8529334
Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
Pharmacogenetics1994PMID 7920690
Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.
Biochemical pharmacology1994PMID 8204093
Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Drug metabolism and disposition: the biological fate of chemicals1993PMID 8095225
Caffeine metabolism and epinephrine responses during exercise in users and nonusers.
Journal of applied physiology (Bethesda, Md.1993PMID 8226485
Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects.
Pharmacology & toxicology1993PMID 8441739
Excretion of caffeine and its primary degradation products into bile.
Journal of hepatology1993PMID 8445222
Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
Pharmacogenetics1992PMID 1302044
Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
European journal of pharmacology1991PMID 1828237
Lack of interaction between lomefloxacin and caffeine in normal volunteers.
Antimicrobial agents and chemotherapy1991PMID 2069371
Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes.
European journal of pharmacology1990PMID 2194822
Effect of paraxanthine on FFA mobilization after intravenous caffeine administration in humans.
Journal of applied physiology (Bethesda, Md.1990PMID 2312486
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.
British journal of clinical pharmacology1989PMID 2713214
Interaction between oral ciprofloxacin and caffeine in normal volunteers.
Antimicrobial agents and chemotherapy1989PMID 2729942
Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
The Journal of pharmacology and experimental therapeutics1989PMID 2913277
Correlation of caffeine elimination and Child's classification in liver cirrhosis.
Klinische Wochenschrift1989PMID 2921843
4-quinolones inhibit biotransformation of caffeine.
European journal of clinical pharmacology1988PMID 2853056
Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines.
Food and chemical toxicology1988PMID 3058562
Caffeine and its dimethylxanthine metabolites in two cases of caffeine overdose: a cause of falsely elevated theophylline concentrations in serum.
Journal of analytical toxicology1988PMID 3072449
Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals1987PMID 2882985
Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.
British journal of clinical pharmacology1986PMID 3756065
Quantitative assessment of caffeine partial clearances in man.
British journal of clinical pharmacology1986PMID 3756066